Executive profile

David Ferreira Moreira, PhD

Chief Financial Officer · Board & Audit Committee Leadership · Biotechnology & Life Sciences · Corporate Governance · AI & Digital Transformation

Connecting finance, science, governance and technology to create sustainable value.

Profile

International finance executive and Chief Financial Officer with a PhD in Finance, currently CFO of FairJourney Biologics, an international biotechnology CRO specialising in antibody discovery and engineering. His focus spans financial strategy, enterprise value creation, performance management, corporate governance, audit and risk oversight, international operations, digital transformation and artificial intelligence.

Board interests

Non-Executive Director, Supervisory Board and Audit & Risk Committee roles, particularly in biotechnology, life sciences, healthcare, technology and private equity-backed companies.

Areas of expertise

Financial & Strategic Leadership
Board Governance, Audit & Risk
Biotechnology, CROs & Drug Discovery
AI, Automation & Digital Transformation
Business Transformation & Value Creation
Investment, Strategy & Stakeholder Management

Selected experience

Chief Financial Officer, FairJourney Biologics (current)
Chief Financial Officer, Motesque
Director, FP&A Europe, Audible, an Amazon company (2019–2020)
Finance roles, Zalando and El Corte Inglés
Independent CFO advisory, Berlin · Prague · Lisbon (since 2013)

Education

PhD in Finance, Prague University of Economics and Business · CS50 for Educators, Harvard University · SQL for Data Science, UC Davis. Author of four peer-reviewed publications on M&A valuation, credit risk and growth finance.

Contact

dfm@davidfmoreira.com · +49 176 32645807 · linkedin.com/in/davidferreiramoreira